Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Farmers Insurance
Argus Health
Harvard Business School

Generated: April 27, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Hospira Inc

« Back to Dashboard

Hospira Inc Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Hospira Inc zoledronic acid 090709 EQ 4MG BASE/5ML INJECTABLE; IV (INFUSION)
Hospira Inc pantoprazole sodium 204400 EQ 40MG BASE/VIAL INJECTABLE; IV (INFUSION)
Hospira Inc pemetrexed disodium 202111 100MG INJECTABLE;INJECTION
Hospira Inc daptomycin 203797 350MG/VIAL POWDER;INTRAVENOUS
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.